Fevara just signed a five-year exclusive deal to distribute LithoNutri, a calcified seaweed rumen buffer made by Brazil's Oceana Minerais Marinhos, across Great Britain and Ireland.
It's a low-cost bet on a big prize: the rumen buffer shelf in UK dairy rations.
Why it matters: the category is currently dominated by Acid Buf, owned by Associated British Foods through its AB Vista and Celtic Sea Minerals units. Fevara is taking on a rival backed by one of the largest food groups in Europe.
A Cheap Way Into a Hard Category
Fevara didn't build a factory. It didn't buy one either.
The company took the fastest route into a new product line: exclusive distribution of someone else's brand.
That avoids the capital cost of building a calcified algae processing plant, and the permitting headache that comes with it. French commercial maerl harvesting largely shut down by 2013. Cornwall banned it in 2005.
The trade-off is margin. Distributors make less than owners. Fevara also accepts counterparty risk on a privately held Brazilian supplier.
The upside is category access without commitment.
The Fevara Story
Fevara used to be Carr's Group.
In April 2025, it sold its engineering business to Cadre Holdings for £75m and returned about £70m to shareholders. Six months later it rebranded as Fevara plc.
Continuing revenue runs at roughly £78m for the year ending August 2025.
The company now sits entirely in specialist livestock supplements: Crystalyx and SmartLic feed blocks, Scotmin minerals, Tracesure boluses, and Biosprint yeast. It also owns Brazilian manufacturing through the Macal and São Paulo acquisitions.
LithoNutri plugs the one big gap in the portfolio: rumen buffers.
Rumen Buffer Background
The pitch to Fevara's sales team is simple.
A rumen buffer costs the farmer £15 to £40 per cow per year. It sits in every dairy ration. Winning that shelf tends to pull the rest of the supplement business with it: calcium, magnesium, trace minerals, yeast, protected fats.
UK dairy is consolidating fast. AHDB counted 7,010 Great Britain producers in October 2025, down 2.6% year over year. Average commercial herd size is 165 cows. Kingshay's larger-herd data puts it at 219.
Bigger herds buy through on-farm nutritionists. They want a coherent product set, not a pile of invoices.
Fevara's legacy strength in pasture beef and sheep doesn't carry into the intensive dairy segment where the money is. The buffer is the entry ticket.
The Incumbent to Beat
Acid Buf is the benchmark. It's made by Marigot Ltd's Celtic Sea Minerals unit in Cork, and distributed across the UK and Ireland by AB Vista. Both sit under AB Agri, and ultimately Associated British Foods.
Same ingredient as LithoNutri: Lithothamnium calcareum calcified red algae. Different geography. Acid Buf comes from Irish subfossil beds and an exclusive Icelandic concession. LithoNutri is harvested off Brazil's Maranhão shelf.
Acid Buf has decades of trial data, more than 50 peer-reviewed studies, and sales in over 40 countries. LithoNutri is new to the UK data set.
To win share, Fevara will need independent UK trials. Compound feeders don't write new ingredients into specifications based on a Brazilian data package.
Fevara's edge is channel. It reaches smaller mineral, block, and merchant customers that AB Vista mostly touches through compounder premix inclusion rather than direct.
Distribution Deals in Animal Nutrition Rarely Stay Distribution Deals
Cargill started with a minority stake in phytogenic additive maker Delacon in 2017. It bought the company outright in 2022. The press release called out a successful five-year partnership.
DSM and Novozymes ran their feed enzyme alliance for about 25 years before Novonesis consolidated it for €1.5bn in 2025. Alltech bought Ridley in 2015 specifically to own the distribution channel. Volac went from a 2003 Malaysian licensing deal with Wilmar to a global joint venture in 2015.
The pattern is consistent. Five years in, partners decide whether to integrate, renew, or walk.
For Fevara, the embedded options are real. Convert to a joint venture. Take a minority stake in Oceana. Negotiate private-label manufacturing rights.
Fevara's Brazilian footprint from Macal and São Paulo makes going upstream easier than it would have been under the old Carr's structure.
Fevara just signed a five-year exclusive deal to distribute LithoNutri, a calcified seaweed rumen buffer made by Brazil's Oceana Minerais Marinhos, across Great Britain and Ireland.
It's a low-cost bet on a big prize: the rumen buffer shelf in UK dairy rations.
Why it matters: the category is currently dominated by Acid Buf, owned by Associated British Foods through its AB Vista and Celtic Sea Minerals units. Fevara is taking on a rival backed by one of the largest food groups in Europe.
A Cheap Way Into a Hard Category
Fevara didn't build a factory. It didn't buy one either.
The company took the fastest route into a new product line: exclusive distribution of someone else's brand.
That avoids the capital cost of building a calcified algae processing plant, and the permitting headache that comes with it. French commercial maerl harvesting largely shut down by 2013. Cornwall banned it in 2005.
The trade-off is margin. Distributors make less than owners. Fevara also accepts counterparty risk on a privately held Brazilian supplier.
The upside is category access without commitment.
The Fevara Story
Fevara used to be Carr's Group.
In April 2025, it sold its engineering business to Cadre Holdings for £75m and returned about £70m to shareholders. Six months later it rebranded as Fevara plc.
Continuing revenue runs at roughly £78m for the year ending August 2025.
The company now sits entirely in specialist livestock supplements: Crystalyx and SmartLic feed blocks, Scotmin minerals, Tracesure boluses, and Biosprint yeast. It also owns Brazilian manufacturing through the Macal and São Paulo acquisitions.
LithoNutri plugs the one big gap in the portfolio: rumen buffers.
Rumen Buffer Background
The pitch to Fevara's sales team is simple.
A rumen buffer costs the farmer £15 to £40 per cow per year. It sits in every dairy ration. Winning that shelf tends to pull the rest of the supplement business with it: calcium, magnesium, trace minerals, yeast, protected fats.
UK dairy is consolidating fast. AHDB counted 7,010 Great Britain producers in October 2025, down 2.6% year over year. Average commercial herd size is 165 cows. Kingshay's larger-herd data puts it at 219.
Bigger herds buy through on-farm nutritionists. They want a coherent product set, not a pile of invoices.
Fevara's legacy strength in pasture beef and sheep doesn't carry into the intensive dairy segment where the money is. The buffer is the entry ticket.
The Incumbent to Beat
Acid Buf is the benchmark. It's made by Marigot Ltd's Celtic Sea Minerals unit in Cork, and distributed across the UK and Ireland by AB Vista. Both sit under AB Agri, and ultimately Associated British Foods.
Same ingredient as LithoNutri: Lithothamnium calcareum calcified red algae. Different geography. Acid Buf comes from Irish subfossil beds and an exclusive Icelandic concession. LithoNutri is harvested off Brazil's Maranhão shelf.
Acid Buf has decades of trial data, more than 50 peer-reviewed studies, and sales in over 40 countries. LithoNutri is new to the UK data set.
To win share, Fevara will need independent UK trials. Compound feeders don't write new ingredients into specifications based on a Brazilian data package.
Fevara's edge is channel. It reaches smaller mineral, block, and merchant customers that AB Vista mostly touches through compounder premix inclusion rather than direct.
Distribution Deals in Animal Nutrition Rarely Stay Distribution Deals
Cargill started with a minority stake in phytogenic additive maker Delacon in 2017. It bought the company outright in 2022. The press release called out a successful five-year partnership.
DSM and Novozymes ran their feed enzyme alliance for about 25 years before Novonesis consolidated it for €1.5bn in 2025. Alltech bought Ridley in 2015 specifically to own the distribution channel. Volac went from a 2003 Malaysian licensing deal with Wilmar to a global joint venture in 2015.
The pattern is consistent. Five years in, partners decide whether to integrate, renew, or walk.
For Fevara, the embedded options are real. Convert to a joint venture. Take a minority stake in Oceana. Negotiate private-label manufacturing rights.
Fevara's Brazilian footprint from Macal and São Paulo makes going upstream easier than it would have been under the old Carr's structure.
What to Watch
First: LithoNutri, or a co-branded version, showing up inside Crystalyx or Scotmin lines. That confirms the bundling strategy is live.
Second: UK or Irish university trial data co-authored with Fevara. That signals the technical development clause is being used.
Third: Brazilian capital expenditure tied to algae processing. That says distribution is a staging post, not the end point.
Without those markers, Fevara has hedged a category rather than entered one. And the Acid Buf position at AB Vista stays the one to beat.